BioTime Presents Updated OpRegen – Business Wire (press release)
|
BioTime Presents Updated OpRegen
Business Wire (press release) OpRegen® is composed of differentiated retinal pigment epithelium cells derived from human stem cells under xeno-free conditions. Observations of the ongoing PI/IIa open-label study and the results to date show that both the surgical procedure used to … |
